Log In
Print this Print this

inhaled nitric oxide (10102-43-9)

  Manage Alerts
Collapse Summary General Information
Company Novoteris LLC
DescriptionInhaled nitric oxide
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Orphan Drug (Treat cystic fibrosis (CF))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today